Mar 15, 2026 by Reuben Gregg BrewerTarget Is Cutting Prices on 3,000 Items As Inflation Drags Down Consumer Spending. Is Inflation Target Stock's Biggest Pain Point Right Now?Target has fallen well behind Walmart, but Target's price cuts may not be enough to get customers back in the door.
Mar 15, 2026 by Adria CiminoIs Vertex Pharmaceuticals Heading to $600?A new product approval may be right around the corner.
Mar 15, 2026 by Courtney CarlsenBetter Nuclear Energy Stock: Oklo vs. Centrus EnergyThe two nuclear energy companies are in the early stages of discussing a joint venture to develop next-generation nuclear fuel, but one looks like a better buy today.
Mar 15, 2026 by David DierkingGrowth Stocks Are Getting Riskier. This ETF Historically Holds Up BetterGrowth stocks are facing a much different environment than the one they enjoyed the past few years. It's time to look at defensive alternatives.
Mar 15, 2026 by Seena HassounaISCG vs. RZG: Which Small-Cap Growth ETF Fits Your Portfolio?Expense ratios, sector tilts, and portfolio breadth set these two small-cap growth ETFs apart for investors weighing their options.
Mar 15, 2026 by Adria CiminoIs Vertex Pharmaceuticals Heading to $600?A new product approval may be right around the corner.
Mar 15, 2026 by Courtney CarlsenBetter Nuclear Energy Stock: Oklo vs. Centrus EnergyThe two nuclear energy companies are in the early stages of discussing a joint venture to develop next-generation nuclear fuel, but one looks like a better buy today.
Mar 15, 2026 by Seena HassounaCBIZ Insider Sale: Trust Move or Warning Sign?CBIZ, Inc., a major business services provider, reported significant insider selling amid a year of sharp share price declines.
Mar 15, 2026 by Katie BrockmanBattle of the Tech ETFs: How IYW and XLK Compare on Risk, Fees, and PerformanceExplore how differences in cost, diversification, and risk set these two tech ETFs apart for investors seeking tailored sector exposure.
Mar 15, 2026 by Geoffrey SeilerGot $1,000? 3 Stocks to Buy in March While They're on Sale.Here's why these stocks are looking like bargain buys.
Mar 15, 2026 by Maurie BackmanMaxed Out Your IRA? Here's What to Do Next.You have a number of options if you're looking to save more.
Mar 15, 2026 by Reuben Gregg BrewerThe Best Stocks to Invest $1,000 in Right NowGiven the market's uncertainty, now is a good time to err on the side of caution... and dividends.
Mar 15, 2026 by Robert IzquierdoIMAX CEO Sold Shares Worth $4.9 Million. Is the Stock a Buy or Sell?IMAX, a global leader in premium cinema technology, reported significant insider selling amid a year of strong stock performance.
Mar 15, 2026 by Jonathan PoncianoInfrastructure Stock Up 67% This Past Year Just Drew a New $6 Million InvestmentThis infrastructure contractor delivers large-scale civil projects and materials for public and private clients across the U.S.
Mar 15, 2026 by Katie BrockmanSPXL vs. TQQQ: Is S&P 500 Stability or Tech-Focused Growth the Better Buy for Leveraged ETF Investors?Explore how sector exposure and risk profiles set these leveraged ETFs apart for traders seeking distinct portfolio dynamics.
Mar 15, 2026 by Jonathan PoncianoWater Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This YearThis water solutions provider serves both consumers and businesses through recurring sales and a broad portfolio of regional brands.
Mar 15, 2026 by Jonathan PoncianoPayments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in RevenueEuronet Worldwide runs a global payments platform, providing transaction processing and money transfer solutions across diverse markets.
Mar 15, 2026 by Reuben Gregg BrewerTarget Is Cutting Prices on 3,000 Items As Inflation Drags Down Consumer Spending. Is Inflation Target Stock's Biggest Pain Point Right Now?Target has fallen well behind Walmart, but Target's price cuts may not be enough to get customers back in the door.
Mar 15, 2026 by Reuben Gregg BrewerIs Signet Jewelers Seriously Undervalued?Shares of Signet Jewelers are up over 70% over the past year, limiting the value appeal of the stock as economic concerns hit consumers.
Mar 15, 2026 by Jonathan PoncianoThis Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share InvestmentEyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships.
Mar 15, 2026 by Geoffrey Seiler2 Artificial Intelligence Stocks You Can Buy and Hold for the Next DecadeAlphabet and Broadcom are two top AI stocks to own.
Mar 15, 2026 by Jonathan PoncianoThis Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal AnnouncementThis medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide.
Mar 15, 2026 by Jonathan PoncianoThis Community Bank With $9 Billion in Assets Just Drew a $2.5 Million Investor BuyOrigin Bancorp delivers banking, lending, and financial services to businesses and consumers across Texas, Louisiana, and Mississippi.
